0001437749-20-024043.txt : 20201116 0001437749-20-024043.hdr.sgml : 20201116 20201116211347 ACCESSION NUMBER: 0001437749-20-024043 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200722 FILED AS OF DATE: 20201116 DATE AS OF CHANGE: 20201116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DE GREEF RODERICK CENTRAL INDEX KEY: 0001241181 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 201319072 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4/A 1 rdgdoc.xml FORM 4/A X0306 4/A 2020-07-22 2020-07-24 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001241181 DE GREEF RODERICK C/O BIOLIFE SOLUTIONS, INC. 3303 MONTE VILLA PARKWAY, SUITE 310 BOTHELL WA 98021 1 CFO & COO Common Stock 2020-07-22 4 A 0 100000 A 158074 D This Form 4/A is being filed to amend the Form 4 (the "Original Form 4") filed by the reporting person on July 24, 2020 to include the restricted stock grant that was granted on July 22, 2020 pursuant to the BioLife Solutions Inc. Second Amended and Restated 2013 Performance Incentive Plan, on Table I rather than Table II. As described in the Original Form 4, the restricted stock vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The information included in column 5 of this Form 4/A reflects the number of securities beneficially owned following the reported transaction on July 22, 2020 assuming all of the restricted shares vested. /s/ Roderick de Greef 2020-11-16